The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.

about

The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.

Item

http://www.wikidata.org/entity/Q45768840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@en

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@nl

type

Item

label

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@en

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@nl

prefLabel

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@en

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@nl

P1476

The prognostic significance of ...... kine ligand 4 in osteosarcoma.

@en

P2093

Aaron J Kelly

http://www.w3.org/2001/XMLSchema#string

Colin McGee

http://www.w3.org/2001/XMLSchema#string

Donald A Barkauskas

http://www.w3.org/2001/XMLSchema#string

John Hicks

http://www.w3.org/2001/XMLSchema#string

Mark Krailo

http://www.w3.org/2001/XMLSchema#string

Xiang Chen

http://www.w3.org/2001/XMLSchema#string

Yiting Li

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of the serum amyloid A (SAA) protein superfamily

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.

Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.

Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.

Platelet-associated PF-4 as a biomarker of early tumor growth.

The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis

P31

scholarly article

P356

10.1002/PBC.26659

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsz-Kwong Man

Ricardo J Flores

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28544777

http://www.w3.org/2001/XMLSchema#string

P932

5695860

http://www.w3.org/2001/XMLSchema#string